Cite
MLA Citation
Peter Ferenci et al.. “A tool for selecting patients with a high probability of sustained virological response to peginterferon alfa‐2a (40kD)/ribavirin.” Liver international, vol. 34, n.d., pp. 1550–1559. http://access.bl.uk/ark:/81055/vdc_100024987570.0x000007